![Matthew McClure](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew McClure
Keine laufenden Positionen mehr
Profil
Matthew W.
McClure worked as a Senior Director at Alios BioPharma, Inc. from 2012 to 2018.
He then served as the Chief Medical Officer at Second Genome, Inc. from 2018 to 2019.
Currently, he is the Chief Medical Officer & Executive Vice President at Aligos Therapeutics, Inc. starting from 2019.
Dr. McClure completed his undergraduate studies at the University of California San Diego and obtained his doctorate degree from Duke University School of Medicine.
Ehemalige bekannte Positionen von Matthew McClure
| Unternehmen | Position | Ende |
|---|---|---|
| ALIGOS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 09.05.2024 |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Develops microbiome-based therapeutic products | General Counsel | 01.06.2019 |
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | Direktor/Vorstandsmitglied | 01.03.2018 |
Ausbildung von Matthew McClure
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | Health Technology |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Develops microbiome-based therapeutic products | Health Technology |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aligos Therapeutics, Inc.
 Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
